Istinye University
🇹🇷Turkey
- Country
- 🇹🇷Turkey
- Ownership
- Private
- Established
- 2015-01-01
- Employees
- 501
- Market Cap
- -
- Website
- https://www.istinye.edu.tr
Clinical Trials
101
Active:3
Completed:46
Trial Phases
1 Phases
Not Applicable:68
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (68 trials with phase data)• Click on a phase to view related trials
Not Applicable
68 (100.0%)Sleep During Recovery: Effect of Preoperative Regional Block on Postoperative Sleep Quality in Mastectomy Patients
Not yet recruiting
- Conditions
- Sleep QualityPostoperative RecoveryAnesthesia Techniques
- First Posted Date
- 2025-07-04
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Istinye University
- Target Recruit Count
- 66
- Registration Number
- NCT07051434
RECOVERY ROOM EARLY WARNING SCORE
Not yet recruiting
- Conditions
- Early Warning Score
- First Posted Date
- 2025-07-04
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Istinye University
- Target Recruit Count
- 208
- Registration Number
- NCT07051421
The Effect of Neuroscience-Based Exercise Training on Shooting Performance and Neuromuscular Performance in Archers
Not Applicable
Not yet recruiting
- Conditions
- ArcheryVisual RehabilitationPhysiotherapy and RehabilitationMuscle ActivityCore Stabilization Exercise Therapy
- First Posted Date
- 2025-07-04
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Istinye University
- Target Recruit Count
- 22
- Registration Number
- NCT07051577
Physical Fitness of Allogeneic Stem Cell Transplant
Recruiting
- Conditions
- Hematopoietic Stem Cell Transplantation
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Istinye University
- Target Recruit Count
- 14
- Registration Number
- NCT07049536
- Locations
- 🇹🇷
Istinye University, Istanbul, Turkey
Diaphragm Function and Urinary Incontinence in Stroke
Not yet recruiting
- Conditions
- Stroke
- First Posted Date
- 2025-07-02
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Istinye University
- Target Recruit Count
- 50
- Registration Number
- NCT07048210
- Prev
- 1
- 2
- 3
- 4
- 5
- 21
- Next
News
Liv Hospital Partners with University of Pennsylvania to Establish Local CAR-T Cell Manufacturing in Turkey
Liv Hospital and Istinye University have signed a comprehensive collaboration with the University of Pennsylvania's Perelman School of Medicine to develop CAR-T cell therapy and proton therapy capabilities in Turkey.
Cemiplimab Shows Significant Survival Benefit in NSCLC Patients with Brain Metastases and High PD-L1 Expression
First-line cemiplimab (Libtayo) monotherapy demonstrated a remarkable survival advantage over chemotherapy in advanced NSCLC patients with PD-L1 ≥50% and brain metastases, with median OS of 52.4 vs 20.7 months.